DermTech Inc (NAS:DMTK)
$ 0.638 0.018 (2.9%) Market Cap: 22.31 Mil Enterprise Value: 20.21 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 44/100

DermTech Inc at BTIG Virtual MedTech, Digital Health, Life Sciences, and Diagnostic Tools Conference Transcript

Feb 17, 2021 / 06:00PM GMT
Release Date Price: $69.46 (-8.18%)
Sung Ji Nam
BTIG, LLC, Research Division - Director and Life Science & Diagnostic Tools Analyst

Welcome. I'm Sung Ji Nam, tools and diagnostics analyst at BTIG. It is my pleasure to introduce DermTech. Presenting for DermTech are John Dobak, President and CEO; and Kevin Sun, CFO. With that, I will turn it over to John for some introductory remarks.

John D. Dobak
DermTech, Inc. - President, CEO & Director

Great. Thank you, Sung Ji, and thanks for everybody who participate in our session right now. DermTech is creating a new category of medicine we refer to as precision dermatology, and this category is enabled by our noninvasive skin genomics platform. What we're able to do is collect a skin sample noninvasively using an adhesive patch. And from the material collected on that patch, we can provide a variety of genomic analyses and provide very accurate diagnosis of skin conditions.

We're mostly focused in skin cancer, and our first product is the Pigmented Lesion Assay, which is a test for melanoma. The test is commercially available across

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot